Cite
MLA Citation
A.J. Ferreri et al.. “CLARITHROMYCIN AS a "REPURPOSING DRUG" AGAINST LYMPHOMAS: SAFETY AND EFFICACY PROFILES IN 55 PATIENTS WITH EXTRANODAL MARGINAL ZONE LYMPHOMA (EMZL).” Hematological oncology, vol. 35, n.d., pp. 86–87. http://access.bl.uk/ark:/81055/vdc_100047425892.0x00002b